Literature DB >> 24858202

Neonatal and early childhood outcomes following early vs later preterm premature rupture of membranes.

Tracy Ann Manuck1, Michael Walter Varner1.   

Abstract

OBJECTIVE: Data regarding long-term outcomes of neonates reaching viability following early preterm premature rupture of membranes (PPROM; <25.0 weeks at rupture) are limited. We hypothesized that babies delivered after early PPROM would have increased rates of major childhood morbidity compared with those with later PPROM (≥25.0 weeks at rupture). STUDY
DESIGN: This was a secondary analysis of a multicenter randomized controlled trial of magnesium sulfate vs placebo for cerebral palsy prevention. Women with singletons and PPROM of 15-32 weeks were included. All women delivered at 24.0 weeks or longer. Those with PPROM less than 25.0 weeks (cases) were compared with women with PPROM at 25.0-31.9 weeks (controls). Composite severe neonatal morbidity (sepsis, severe intraventricular hemorrhage, periventricular leukomalacia, severe necrotizing enterocolitis, bronchopulmonary dysplasia, and/or death) and composite severe childhood morbidity at age 2 years (moderate or severe cerebral palsy and/or Bayley II Infant and Toddler Development scores greater than 2 SD below the mean) were compared.
RESULTS: A total of 1531 women (275 early PPROM cases) were included. Demographics were similar between the groups. Cases delivered earlier (26.6 vs 30.1 weeks, P < .001) and had a longer rupture-to-delivery interval (20.0 vs 10.4 days, P < .001). Case neonates had high rates of severe composite neonatal morbidity (75.6% vs 21.8%, P < .001). Children with early PPROM had higher composite severe childhood morbidity (51.6% vs 22.5%, P < .001). Early PPROM remained associated with composite severe childhood morbidity in multivariable models, even when controlling for delivery gestational age and other confounders.
CONCLUSION: Early PPROM is associated with high rates of neonatal morbidity. Early childhood outcomes at age 2 years remain poor compared with those delivered after later PPROM. Published by Elsevier Inc.

Entities:  

Keywords:  childhood outcomes; neonatal outcomes; preterm premature rupture of membranes

Mesh:

Year:  2014        PMID: 24858202      PMCID: PMC4270010          DOI: 10.1016/j.ajog.2014.05.030

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  Births: preliminary data for 2012.

Authors:  Brady E Hamilton; Joyce A Martin; Stephanie J Ventura
Journal:  Natl Vital Stat Rep       Date:  2013-09

2.  Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: a metaanalysis.

Authors:  C Egarter; H Leitich; H Karas; F Wieser; P Husslein; A Kaider; M Schemper
Journal:  Am J Obstet Gynecol       Date:  1996-02       Impact factor: 8.661

3.  Factors affecting the duration of the latency period in preterm premature rupture of membranes.

Authors:  Nir Melamed; Eran Hadar; Avi Ben-Haroush; Boris Kaplan; Yariv Yogev
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

4.  Neonatal outcomes and four-year follow-up after spontaneous or iatrogenic preterm prelabor rupture of membranes before 24 weeks.

Authors:  Céline Chauleur; Stéphanie Rochigneux; Pierre Seffert; Gautier Chene; Karen Billiemaz; Frédérique Collet
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

5.  Neonatal outcome and two-year follow-up after expectant management of second trimester rupture of membranes.

Authors:  Gunda Pristauz; Margit Bauer; Ute Maurer-Fellbaum; Christa Rotky-Fast; Arnim A Bader; Josef Haas; Uwe Lang
Journal:  Int J Gynaecol Obstet       Date:  2008-03-04       Impact factor: 3.561

Review 6.  The management of preterm premature rupture of the membranes near the limit of fetal viability.

Authors:  Thaddeus P Waters; Brian M Mercer
Journal:  Am J Obstet Gynecol       Date:  2009-09       Impact factor: 8.661

Review 7.  Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis.

Authors:  Carolyn E Hutzal; Elaine M Boyle; Sara L Kenyon; Jennifer V Nash; Stephanie Winsor; David J Taylor; Haresh Kirpalani
Journal:  Am J Obstet Gynecol       Date:  2008-10-30       Impact factor: 8.661

8.  Outcomes of expectantly managed preterm premature rupture of membranes occurring before 24 weeks of gestation.

Authors:  Tracy A Manuck; Alexandra G Eller; M Sean Esplin; Gregory J Stoddard; Michael W Varner; Robert M Silver
Journal:  Obstet Gynecol       Date:  2009-07       Impact factor: 7.661

9.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

Review 10.  Epidemiology and causes of preterm birth.

Authors:  Robert L Goldenberg; Jennifer F Culhane; Jay D Iams; Roberto Romero
Journal:  Lancet       Date:  2008-01-05       Impact factor: 79.321

View more
  17 in total

1.  Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Piya Chaemsaithong; Roberto Romero; Nikolina Docheva; Noppadol Chaiyasit; Gaurav Bhatti; Percy Pacora; Sonia S Hassan; Lami Yeo; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-01

2.  Mid-childhood outcomes after pre-viable preterm premature rupture of membranes.

Authors:  M H Bentsen; E Satrell; H Reigstad; S L Johnsen; M Vollsæter; O D Røksund; G Greve; A Berg; T Markestad; T Halvorsen
Journal:  J Perinatol       Date:  2017-06-29       Impact factor: 2.521

3.  A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection.

Authors:  Piya Chaemsaithong; Roberto Romero; Steven J Korzeniewski; Alicia Martinez-Varea; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2015-03-23

4.  Offering induction of labor for 22-week premature rupture of membranes: a survey of obstetricians.

Authors:  F McKenzie; B Tucker Edmonds
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

5.  A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.

Authors:  JoonHo Lee; Roberto Romero; Sun Min Kim; Piya Chaemsaithong; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-16

6.  Associations of Maternal Testosterone and Cortisol Levels With Health Outcomes of Mothers and Their Very-Low-Birthweight Infants.

Authors:  June Cho; Xiaogang Su; Diane Holditch-Davis
Journal:  Biol Res Nurs       Date:  2017-04-12       Impact factor: 2.522

7.  Evidence of perturbations of the cytokine network in preterm labor.

Authors:  Roberto Romero; Jean-Charles Grivel; Adi L Tarca; Piya Chaemsaithong; Zhonghui Xu; Wendy Fitzgerald; Sonia S Hassan; Tinnakorn Chaiworapongsa; Leonid Margolis
Journal:  Am J Obstet Gynecol       Date:  2015-07-29       Impact factor: 8.661

8.  A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM.

Authors:  JoonHo Lee; Roberto Romero; Sun Min Kim; Piya Chaemsaithong; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-02

9.  Clinical chorioamnionitis at term VIII: a rapid MMP-8 test for the identification of intra-amniotic inflammation.

Authors:  Noppadol Chaiyasit; Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Gaurav Bhatti; Juan Pedro Kusanovic; Zhong Dong; Lami Yeo; Percy Pacora; Sonia S Hassan; Offer Erez
Journal:  J Perinat Med       Date:  2017-07-26       Impact factor: 1.901

10.  An elevated amniotic fluid prostaglandin F2α concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Jee Yoon Park; Roberto Romero; JoonHo Lee; Piya Chaemsaithong; Noppadol Chaiyasit; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.